Stephan Kontos

1.0k total citations
14 papers, 788 citations indexed

About

Stephan Kontos is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Stephan Kontos has authored 14 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Stephan Kontos's work include T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Stephan Kontos is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Stephan Kontos collaborates with scholars based in Switzerland, United States and South Korea. Stephan Kontos's co-authors include Jeffrey A. Hubbell, Iraklis C. Kourtis, Karen Y. Dane, Kristen M. Lorentz, Giacomo Diaceri, Alizée J Grimm, Pascal Frey, Jeong Mook Lim, Seung Tae Lee and André J. van der Vlies and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Gastroenterology.

In The Last Decade

Stephan Kontos

14 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Kontos Switzerland 13 307 253 198 142 132 14 788
Teresa Lopes Ramos Spain 16 353 1.1× 226 0.9× 68 0.3× 85 0.6× 156 1.2× 44 967
Qingfeng Chen Singapore 14 395 1.3× 198 0.8× 179 0.9× 76 0.5× 81 0.6× 20 825
Woon Teck Yap United States 8 282 0.9× 497 2.0× 108 0.5× 89 0.6× 129 1.0× 10 852
Min Kyung Kim South Korea 14 293 1.0× 363 1.4× 92 0.5× 64 0.5× 64 0.5× 19 772
Yoko Itakura Japan 16 504 1.6× 203 0.8× 113 0.6× 100 0.7× 107 0.8× 32 755
Zoe Hunter United States 11 303 1.0× 558 2.2× 84 0.4× 54 0.4× 78 0.6× 15 940
Iraklis C. Kourtis Switzerland 5 308 1.0× 602 2.4× 152 0.8× 83 0.6× 74 0.6× 5 916
Brian A. MacDonald United States 9 388 1.3× 93 0.4× 91 0.5× 78 0.5× 85 0.6× 13 923
Daniela Segat Italy 19 355 1.2× 98 0.4× 80 0.4× 137 1.0× 73 0.6× 32 844
Xiaoli Wei China 13 332 1.1× 217 0.9× 312 1.6× 137 1.0× 76 0.6× 30 776

Countries citing papers authored by Stephan Kontos

Since Specialization
Citations

This map shows the geographic impact of Stephan Kontos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Kontos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Kontos more than expected).

Fields of papers citing papers by Stephan Kontos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Kontos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Kontos. The network helps show where Stephan Kontos may publish in the future.

Co-authorship network of co-authors of Stephan Kontos

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Kontos. A scholar is included among the top collaborators of Stephan Kontos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Kontos. Stephan Kontos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Murray, Joseph A., Dina Wassaf, Karen Dunn, et al.. (2023). Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial. ˜The œLancet. Gastroenterology & hepatology. 8(8). 735–747. 34 indexed citations
2.
Murray, Joseph A., Karen Dunn, Samir Arora, et al.. (2022). 579: SAFETY, TOLERABILITY AND PHARMACODYNAMIC ASSESSMENT OF KAN-101, A NOVEL LIVER-TARGETED THERAPY TO INDUCE IMMUNOLOGICAL TOLERANCE TO GLIADIN IN CELIAC DISEASE. Gastroenterology. 162(7). S–141. 2 indexed citations
3.
Watkins, Elyse A., et al.. (2021). Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Science Immunology. 6(56). 20 indexed citations
4.
Grimm, Alizée J, et al.. (2015). Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Scientific Reports. 5(1). 15907–15907. 65 indexed citations
5.
Kontos, Stephan, Alizée J Grimm, & Jeffrey A. Hubbell. (2015). Engineering antigen-specific immunological tolerance. Current Opinion in Immunology. 35. 80–88. 28 indexed citations
6.
Lorentz, Kristen M., Stephan Kontos, Giacomo Diaceri, Hugues Henry, & Jeffrey A. Hubbell. (2015). Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase. Science Advances. 1(6). e1500112–e1500112. 72 indexed citations
7.
Morales‐Sanfrutos, Julia, et al.. (2014). Bicyclic Peptides Conjugated to an Albumin-Binding Tag Diffuse Efficiently into Solid Tumors. Molecular Cancer Therapeutics. 14(1). 151–161. 23 indexed citations
8.
Lean, Fabian Z. X., Stephan Kontos, & Chiara Palmieri. (2014). Expression of β-catenin and Mesenchymal Markers in Canine Prostatic Hyperplasia and Carcinoma. Journal of Comparative Pathology. 150(4). 373–381. 13 indexed citations
9.
Kourtis, Iraklis C., Sachiko Hirosue, Alexandre de Titta, et al.. (2013). Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice. PLoS ONE. 8(4). e61646–e61646. 107 indexed citations
10.
Lee, Seung Tae, Jung Im Yun, André J. van der Vlies, et al.. (2012). Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3. Biomaterials. 33(35). 8934–8942. 23 indexed citations
11.
Kontos, Stephan & Jeffrey A. Hubbell. (2012). Drug development: longer-lived proteins. Chemical Society Reviews. 41(7). 2686–2686. 60 indexed citations
12.
Kontos, Stephan, Iraklis C. Kourtis, Karen Y. Dane, & Jeffrey A. Hubbell. (2012). Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proceedings of the National Academy of Sciences. 110(1). E60–8. 161 indexed citations
13.
Lorentz, Kristen M., Stephan Kontos, Pascal Frey, & Jeffrey A. Hubbell. (2010). Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials. 32(2). 430–438. 68 indexed citations
14.
Lee, Seung Tae, Jung Im Yun, Yun Suk Jo, et al.. (2009). Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials. 31(6). 1219–1226. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026